Product Description:

Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase domains of both EGFR (ErbB1) and of HER2 (ErbB2) receptors. Lapatinib retained significant activity against HER2-amplified breast cancer cell lines selected for long-term growth in trastuzumab-containing medium in vitro and was synergistic in combination with trastuzumab in these cell lines.

Product Features:

Product Name : Lapanix
Generic Name : Lapatinib
Formulation : Tablet
Available Pack Size : 150’s Pot
Available Strength : 250 mg
Registrations : Export Only
Website :